Replacement of arginine 773 by cysteine or histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes.
- 1 July 1992
- journal article
- Vol. 51 (1) , 143-55
Abstract
We have discovered two different point mutations in a single codon of the X-linked androgen-receptor (AR) gene in two pairs of unrelated families who have complete androgen insensitivity (resistance) associated with different AR phenotypes in their genital skin fibroblasts. One mutation is a C-to-T transition at a CpG sequence near the 5' terminus of exon 6; it changes the sense of codon 773 from arginine to cysteine, ablates specific androgen-binding activity at 37 degrees C, and eliminates a unique KpnI site at the intron-exon boundary. The other mutation is a G-to-A transition that changes amino acid 773 to histidine and eliminates an SphI site. This mutant AR has a normal androgen-binding capacity at 37 degrees C but has a reduced affinity for androgens and is thermolabile in their presence. Transient transfection of COS cells with cDNA expression vectors yielded little androgen-binding activity at 37 degrees C from Arg773Cys and abundant activity with abnormal properties from Arg773His, thereby providing the pathogenicity of both sequence alterations. This conclusion coincides with the following facts about evolutionary preservation of the position homologous to Arg773 in the AR: it is occupied by Arg or lysine in the progesterone, glucocorticoid, and mineralocorticoid receptors, and it is within a 14-amino-acid region of their steroid-binding domains that share approximately 85% amino acid identity.This publication has 34 references indexed in Scilit:
- Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy.Journal of Clinical Investigation, 1991
- A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance.Journal of Clinical Investigation, 1991
- The 56/58 kDa androgen-binding protein in male genital skin fibroblasts with a deleted androgen receptor geneMolecular and Cellular Endocrinology, 1991
- Epitope prediction and confirmation for the human androgen receptor: Generation of monoclonal antibodies for multi-assay performance following the synthetic peptide strategyBiochimica et Biophysica Acta (BBA) - General Subjects, 1991
- Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations.Journal of Medical Genetics, 1989
- MOSAICISM AND SPORADIC HAEMOPHILIA: IMPLICATIONS FOR CARRIER DETERMINATIONThe Lancet, 1989
- Mosaicism for an Intragenic Deletion in a Boy with Mild Ornithine Transcarbamylase DeficiencyNew England Journal of Medicine, 1988
- Extracellular correction of the androgen-receptor transformation defect in two families with complete androgen resistanceThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probesCell, 1980
- Male pseudohermaphroditism presumably due to target organ unresponsiveness to androgens. Deficient 5alpha-dihydrotestosterone binding in cultured skin fibroblasts.Journal of Clinical Investigation, 1976